Menard Financial Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,350
| Closed | -$1.06M | – | 245 |
|
|
2024
Q4 | $1.06M | Buy |
12,350
+67
| +0.5% | +$5.76K | 0.64% | 34 |
|
|
2024
Q3 | $1.46M | Buy |
12,283
+102
| +0.8% | +$12.1K | 0.96% | 21 |
|
|
2024
Q2 | $1.74M | Buy |
12,181
+141
| +1% | +$20.1K | 1.24% | 16 |
|
|
2024
Q1 | $1.55M | Sell |
12,040
-1,834
| -13% | -$235K | 1.3% | 15 |
|
|
2023
Q4 | $1.44M | Buy |
13,874
+111
| +0.8% | +$11.5K | 1.78% | 12 |
|
|
2023
Q3 | $1.25M | Buy |
13,763
+9,527
| +225% | +$866K | 1.81% | 11 |
|
|
2023
Q2 | $343K | Buy |
+4,236
| New | +$343K | 0.7% | 29 |
|